FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2522646258> ?p ?o ?g. }

• W2522646258 abstract "Hsp90 proteins are important therapeutic targets for many anti-cancer drugs in clinical trials. Geldanamycin (GA) was identified as the first natural inhibitor of Hsp90, increasing evidence suggests that GA was not a good choice for clinical trials. In this study, we investigated two new non-benzoquinone geldanamycin analogs of Hsp90 inhibitors, DHQ3 and 17-demethoxy-reblastatin (17-DR), to explore the molecular mechanisms of their anti-cancer activity in vivo and vitro.MTT and colony formation assays were used to measure cell viability. Flow cytometry, DAPI staining, ATP assay, electron microscopy, western blots, siRNAs transfection and immunofluorescence were used to determine the molecular mechanism of DHQ3- or 17-DR-induced different forms of death in human breast cancer MDA-MB-231 cells. Malachite green reagent was used to measure ATPase activity of the analogs.DHQ3 and 17-DR presented efficiently inhibitory effect in MDA-MB-231 cell lines, and DHQ3 induced necroptosis by activation of the RIP1-RIP3-MLKL necroptosis cascade. And DHQ3-induced cell death was inhibited by a necroptosis inhibitor, necrostatin-1 (Nec-1), but not by a caspase inhibitor z-VAD-fmk. On the other hand, 17-DR induced apoptosis in MDA-MB-231 cells, indicating a caspase-dependent killing mechanism. We further demonstrated that down-regulation of RIP1 and RIP3 by siRNA protected against DHQ3 but not 17-DR induced cell death. These results were confirmed by electron microscopy. DHQ3 and 17-DR induced the degradation of Hsp90 client proteins, and they showed strong antitumor effects in MDA-MB-231 cell-xenografted nude mice.These findings supported that DHQ3 and 17-DR induce different forms of death in some cancer cell line via activation of different pathways. All of the results provided evidence for its anti-tumorigentic action with low hepatotoxicity in vivo, making them promising anti-breast cancer agents." @default.
• W2522646258 created "2016-09-30" @default.
• W2522646258 creator A5002481882 @default.
• W2522646258 creator A5012134741 @default.
• W2522646258 creator A5020691605 @default.
• W2522646258 creator A5028604823 @default.
• W2522646258 creator A5035459702 @default.
• W2522646258 creator A5036045593 @default.
• W2522646258 creator A5044598723 @default.
• W2522646258 creator A5056422120 @default.
• W2522646258 creator A5058346980 @default.
• W2522646258 creator A5058456199 @default.
• W2522646258 creator A5080278566 @default.
• W2522646258 creator A5084844090 @default.
• W2522646258 creator A5088664989 @default.
• W2522646258 date "2016-09-22" @default.
• W2522646258 modified "2023-10-15" @default.
• W2522646258 title "Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells" @default.
• W2522646258 cites W1244549481 @default.
• W2522646258 cites W1578095196 @default.
• W2522646258 cites W1667963444 @default.
• W2522646258 cites W1670035560 @default.
• W2522646258 cites W1757407923 @default.
• W2522646258 cites W1850224498 @default.
• W2522646258 cites W1970053539 @default.
• W2522646258 cites W1974941717 @default.
• W2522646258 cites W1978844022 @default.
• W2522646258 cites W1979032223 @default.
• W2522646258 cites W2000929246 @default.
• W2522646258 cites W2003786318 @default.
• W2522646258 cites W2020987391 @default.
• W2522646258 cites W2029243355 @default.
• W2522646258 cites W2035604845 @default.
• W2522646258 cites W2050753030 @default.
• W2522646258 cites W2060204808 @default.
• W2522646258 cites W2060902443 @default.
• W2522646258 cites W2064247262 @default.
• W2522646258 cites W2068169474 @default.
• W2522646258 cites W2086655378 @default.
• W2522646258 cites W2087684358 @default.
• W2522646258 cites W2089082840 @default.
• W2522646258 cites W2094726531 @default.
• W2522646258 cites W2110796758 @default.
• W2522646258 cites W2111187586 @default.
• W2522646258 cites W2118643338 @default.
• W2522646258 cites W2120626244 @default.
• W2522646258 cites W2132161879 @default.
• W2522646258 cites W2133079836 @default.
• W2522646258 cites W2144818233 @default.
• W2522646258 cites W2158294714 @default.
• W2522646258 cites W2158662692 @default.
• W2522646258 cites W2169109415 @default.
• W2522646258 cites W2173081403 @default.
• W2522646258 cites W2231291760 @default.
• W2522646258 cites W2272315791 @default.
• W2522646258 cites W2340716273 @default.
• W2522646258 cites W2364176754 @default.
• W2522646258 cites W2395769901 @default.
• W2522646258 cites W4245469960 @default.
• W2522646258 doi "https://doi.org/10.1186/s13046-016-0428-6" @default.
• W2522646258 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5034425" @default.
• W2522646258 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27658586" @default.
• W2522646258 hasPublicationYear "2016" @default.
• W2522646258 type Work @default.
• W2522646258 sameAs 2522646258 @default.
• W2522646258 citedByCount "19" @default.
• W2522646258 countsByYear W25226462582017 @default.
• W2522646258 countsByYear W25226462582018 @default.
• W2522646258 countsByYear W25226462582019 @default.
• W2522646258 countsByYear W25226462582020 @default.
• W2522646258 countsByYear W25226462582021 @default.
• W2522646258 countsByYear W25226462582022 @default.
• W2522646258 countsByYear W25226462582023 @default.
• W2522646258 crossrefType "journal-article" @default.
• W2522646258 hasAuthorship W2522646258A5002481882 @default.
• W2522646258 hasAuthorship W2522646258A5012134741 @default.
• W2522646258 hasAuthorship W2522646258A5020691605 @default.
• W2522646258 hasAuthorship W2522646258A5028604823 @default.
• W2522646258 hasAuthorship W2522646258A5035459702 @default.
• W2522646258 hasAuthorship W2522646258A5036045593 @default.
• W2522646258 hasAuthorship W2522646258A5044598723 @default.
• W2522646258 hasAuthorship W2522646258A5056422120 @default.
• W2522646258 hasAuthorship W2522646258A5058346980 @default.
• W2522646258 hasAuthorship W2522646258A5058456199 @default.
• W2522646258 hasAuthorship W2522646258A5080278566 @default.
• W2522646258 hasAuthorship W2522646258A5084844090 @default.
• W2522646258 hasAuthorship W2522646258A5088664989 @default.
• W2522646258 hasBestOaLocation W25226462581 @default.
• W2522646258 hasConcept C104317684 @default.
• W2522646258 hasConcept C121608353 @default.
• W2522646258 hasConcept C153911025 @default.
• W2522646258 hasConcept C185592680 @default.
• W2522646258 hasConcept C190283241 @default.
• W2522646258 hasConcept C205260736 @default.
• W2522646258 hasConcept C2775932338 @default.
• W2522646258 hasConcept C2777527632 @default.
• W2522646258 hasConcept C2777560012 @default.
• W2522646258 hasConcept C2780297055 @default.
• W2522646258 hasConcept C31573885 @default.
• W2522646258 hasConcept C502942594 @default.

• next